These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1624021)

  • 21. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries].
    Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
    Papaleo E; Doldi N; De Santis L; Marelli G; Marsiglio E; Rofena S; Ferrari A
    Hum Reprod; 2001 Nov; 16(11):2263-6. PubMed ID: 11679501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
    Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
    Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transvaginal ultrasonic assessment of the response to clomiphene citrate in polycystic ovarian syndrome.
    Takahashi K; Uchida A; Yamasaki H; Ozaki T; Kitao M
    Fertil Steril; 1994 Jul; 62(1):48-53. PubMed ID: 8005303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM; MacLachlan V; Montalto J; Calderon I; Healy DL; McLachlan RI
    Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization.
    Tomas C; Nuojua-Huttunen S; Martikainen H
    Hum Reprod; 1997 Feb; 12(2):220-3. PubMed ID: 9070699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.
    MacDougall MJ; Tan SL; Balen A; Jacobs HS
    Hum Reprod; 1993 Feb; 8(2):233-7. PubMed ID: 8473426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome?
    Sunj M; Canic T; Baldani DP; Tandara M; Jeroncic A; Palada I
    Hum Reprod; 2013 Sep; 28(9):2417-24. PubMed ID: 23820423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women.
    Agrawal R; Sharma S; Bekir J; Conway G; Bailey J; Balen AH; Prelevic G
    Fertil Steril; 2004 Nov; 82(5):1352-7. PubMed ID: 15533359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of polycystic ovaries in a girl with hypogonadotropic hypogonadism before puberty and during puberty induced with pulsatile gonadotropin-releasing hormone.
    Stanhope R; Adams J; Pringle JP; Jacobs HS; Brook CG
    Fertil Steril; 1987 May; 47(5):872-5. PubMed ID: 3552755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.
    Hahn S; Bering van Halteren W; Roesler S; Schmidt M; Kimmig R; Tan S; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):175-81. PubMed ID: 16705549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and endocrine features of ultrasound diagnosed polycystic ovary patients: the correlation between ovarian volume and androgen activity.
    Turhan NO; Senoz S; Gulekli B; Ozaksit G; Oral H; Gokmen O
    J Pak Med Assoc; 1993 Jan; 43(1):4-6. PubMed ID: 8474219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.
    Fulghesu AM; Villa P; Pavone V; Guido M; Apa R; Caruso A; Lanzone A; Rossodivita A; Mancuso S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):644-8. PubMed ID: 9024269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.